ACTIVE PROLIFERATIVE LUPUS NEPHRITIS

Clinical trials for ACTIVE PROLIFERATIVE LUPUS NEPHRITIS explained in plain language.

Never miss a new study

Get alerted when new ACTIVE PROLIFERATIVE LUPUS NEPHRITIS trials appear

Sign up with your email to follow new studies for ACTIVE PROLIFERATIVE LUPUS NEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New lupus drug shows promise in early safety trial

Disease control Completed

This early-stage study tested a drug called itolizumab (EQ001) in 52 adults with lupus, some of whom also had active kidney disease. The main goal was to check the drug's safety and how the body processes it. Researchers also looked at how the drug attaches to immune cells to bet…

Matched conditions: ACTIVE PROLIFERATIVE LUPUS NEPHRITIS

Phase: PHASE1 • Sponsor: Biocon Limited • Aim: Disease control

Last updated Jun 17, 2026 04:25 UTC

ACTIVE PROLIFERATIVE LUPUS NEPHRITIS

Get alerted when new ACTIVE PROLIFERATIVE LUPUS NEPHRITIS trials appear

New lupus drug shows promise in early safety trial